Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BBIO BridgeBio Pharma Inc

-1.14 (-3.93%)
Jun 14 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,132,085
Bid Price 26.77
Ask Price 29.50
News -
Day High 28.55


52 Week Range


Day Low 27.47
Company Name Stock Ticker Symbol Market Type
BridgeBio Pharma Inc BBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.14 -3.93% 27.86 20:00:00
Open Price Low Price High Price Close Price Prev Close
28.43 27.47 28.55 27.86 29.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
15,585 1,132,085 $ 27.91 $ 31,593,987 - 14.7755 - 44.32
Last Trade Time Type Quantity Stock Price Currency
19:57:45 20 $ 28.97 USD

BridgeBio Pharma (BBIO) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


BridgeBio Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.9B 175.83M - 9.3M -643.2M -3.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BridgeBio Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BBIO Message Board. Create One! See More Posts on BBIO Message Board See More Message Board Posts

Historical BBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week26.7229.3426.5328.021,263,8901.144.27%
1 Month30.7731.43526.5328.241,710,984-2.91-9.46%
3 Months29.0031.43523.6827.831,577,847-1.14-3.93%
6 Months36.0944.3223.6832.351,780,225-8.23-22.80%
1 Year16.8344.3214.775529.932,038,16211.0365.54%
3 Years64.8265.334.9820.512,083,542-36.96-57.02%
5 Years30.6173.504.9824.261,508,121-2.75-8.98%

BridgeBio Pharma Description

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.

Your Recent History

Delayed Upgrade Clock